The investigation concerns whether the Company made numerous false and misleading statements concerning the level of regulatory risk faced by the Original Merger and the Revised Merger. On October 27, 2015, Rite Aid and Walgreens Boots Alliance, Inc. (“Walgreens”) jointly announced an Agreement and Plan of Merger (the “Original Merger Agreement”) pursuant to which Walgreens would acquire Rite Aid for $9.00 per share in cash. On January 30, 2017, Rite Aid and Walgreens announced that they had entered into a new merger agreement (the “Revised Merger Agreement”), which cut the proposed consideration for Rite Aid stockholders from $9.00 per share to between $6.50 to $7.00 per share. On June 29, 2017, Rite Aid and Walgreens announced that they had terminated the Revised Merger Agreement.

If you purchased Rite Aid securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.